Olive Oil Phonophoresis and Chronic Low Back

The Effect of Olive Oil Phonophoresis on Chronic Low Back Pain in Female Athletes: a Randomized Controlled Trial

Status

UNKNOWN

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01772433

Enrollment

Registered

2013-01-21

Start date

2013-01-31

Completion date

2013-10-31

Last updated

2013-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Keywords

Low Back Pain, Topical Olive Oil, Phonophoresis

Brief summary

This study is intended to evaluate the effect of olive oil phonophoresis on chronic law back pain in female athletes.

Detailed description

This study will enroll 60 female patients suffering from chronic low back pain. the study will run in single blind mode that only patients will kept unaware of treatment. The duration of treatment is 10 days. patients will be assigned randomly to olive oil or placebo group. every day, they will take phonophoresis on lower back using phonophoresis gel as placebo or olive oil as treatment for 10 day. the questionnaires will be filled in baseline visit and day 10. any side effect of drugs or technique will be recorded

Interventions

DIETARY_SUPPLEMENTOlive oil

Phonophoresis with Olive oil for 10 day, daily

DRUGPhonophoresis gel

Phonophoresis with base gel for 10 days, daily

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 40 Years

Healthy volunteers

Inclusion criteria

* Young female athletes suffering from low back pain for more than three months

Exclusion criteria

* Underlying systematic or visceral disease * Specific conditions such as neoplasm and fractures, spondylolisthesis * Previous low back surgery * Pregnancy

Design outcomes

Primary

Measure	Time frame	Description
Pain Score	Change from Baseline in McGill Low Back Pain Scale at day 10	Low back pain intensity will be measured using McGill questionnaire from 0 (no pain) to 10 (worst).

Secondary

Measure	Time frame	Description
Physical function	Change from Baseline in Phycical Function Scale at Day 10	The ability of patients in doing daily activities will be measured using two qualified questionnaires

Other

Measure	Time frame	Description
Safety	Day 10	Any occurrence of drug induced side effects will be recorded

Countries

Iran

Contacts

Primary ContactShahab Bohlooli, PhD

shahab.bohlooli@arums.ac.ir

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026